About Kenay – KENAY Boswellis Casperome Indena Phytosome – extract (60 caps)

KENAY Boswellis Casperome® is a premium Boswellia serrata supplement featuring the patented Indena Phytosome® technology, which combines frankincense resin extract with sunflower lecithin to support superior absorption compared to standard Boswellia extracts. Each daily serving of 2 capsules delivers 800 mg of the Casperome® formula, providing 280 mg of concentrated frankincense extract standardised to contain a minimum of 25% triterpene acids and 20% boswellic acids.

Boswellia serrata, also known as Indian frankincense, is a well-regarded botanical ingredient with a long history of traditional use. The Phytosome® delivery system binds the active plant compounds to phospholipids, making this formulation a sophisticated choice for those seeking a high-quality, well-characterised Boswellia supplement.

Presented in convenient vegetarian Vcaps® capsules made from hydroxypropylmethylcellulose, each pack contains 60 capsules — a 30-day supply at the recommended dose. This formulation is free from lactose and is suitable for vegetarians.

Informations nutritionnelles

Nutriment	Par portion (2 gélules)
Casperome® Indena Phytosome formula	800 mg
– of which frankincense extract (Boswellia serrata)	280 mg
– – of which triterpene acids (min. 25%)	70 mg
– – of which boswellic acids (alpha and beta, min. 20%)	14 mg

Ingrédients

Frankincense resin extract (Boswellia serrata), standardized to contain: triterpenes: 25%, boswellic acids: 20%; antioxidant: sunflower lecithin; emulsifier: cellulose; anti-caking agent: silicon dioxide; capsule: hydroxypropylmethylcellulose.

Capsule shell: Hydroxypropylmethylcellulose (Vcaps®, trademark of Lonza or its affiliates)

Mode d'emploi et posologie

2 capsules per day: 1 capsule in the morning and 1 capsule in the evening.

Avertissements

Do not exceed the recommended daily dose. Dietary supplements cannot be used as a substitute for a varied diet. The preparation should not be used by pregnant or breastfeeding women, or by children and adolescents under 18 years of age.